Akagera Medicines Inc.
Waltham, MA Akagera Medicines, Inc.
- UEI
- Y6U5VK97MD53
- CAGE
- 0Q1Z4
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 271 Waverley Oaks Rd #100, Waltham, MA 02452, USA
- Website
- akageramedicines.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Quick answers
What is Akagera Medicines Inc.'s UEI?
Akagera Medicines Inc.'s Unique Entity ID (UEI) in SAM.gov is Y6U5VK97MD53.
What is Akagera Medicines Inc.'s CAGE code?
Akagera Medicines Inc.'s CAGE code is 0Q1Z4.
What is Akagera Medicines Inc.'s primary NAICS code?
Akagera Medicines Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is Akagera Medicines Inc. located?
Akagera Medicines Inc.'s physical address in SAM.gov is 271 Waverley Oaks Rd #100, Waltham, MA 02452, USA.
Is Akagera Medicines Inc. registered in SAM.gov?
Yes. Akagera Medicines Inc.'s SAM.gov registration is active through September 23, 2027.
On GovTribe
See Akagera Medicines Inc.'s full federal record
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors